In ALS models, gene therapy approaches that target Sig-1R function restoration or enhancement, or modify its downstream pathways, offer a promising means of improving proteostasis, mitochondrial health, and overall neuronal survival [173]. This evidence concerns the gene SIGMAR1 and amyotrophic lateral sclerosis.